Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

NASDAQ:LGND   3:59:57 PM EDT
156.83
+2.61 (+1.69%)
Other Pre-Announcement

Ligand Pharmaceuticals Posts Q3 EPS Of $0.80

Published: 11/09/2021 21:52 GMT
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B (LGND) - Ligand Reports Third Quarter 2021 Financial Results.
Sees FY Adjusted Earnings per Share $5.80 to $6.05.
Q3 Adjusted Earnings per Share $1.58.
Q3 Earnings per Share $0.80.
Sees FY Revenue $265 Million to $275 Million.
Q3 Revenue $64.8 Million.
Q3 Earnings per Share View $1.04, Revenue View $55.7 Million -- Refinitiv Ibes Data (analyst estimates).
FY2021 Earnings per Share View $5.93, Revenue View $270.8 Million -- Refinitiv Ibes Data (analyst estimates).